Margaret A. Shipp
0000-0002-3949-6897
Publication & Citation Trends
Publications
0 total
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors OA
Cited by 0
Semantic Scholar
Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study
Cited by 1
Semantic Scholar
Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826
Cited by 0
Semantic Scholar
3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma
Cited by 3
Semantic Scholar
Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers
Cited by 0
Semantic Scholar
Murine modeling of cluster 1 diffuse large B-cell lymphoma reveals transformation from marginal zone lymphoma
Cited by 0
Semantic Scholar
Relapsed diffuse large B-cell lymphoma is shaped by molecular subtypes and genomic alterations
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(242)
Cancer Immunotherapy and Biomarkers
(93)
CAR-T cell therapy research
(77)
Chronic Lymphocytic Leukemia Research
(75)
Immune Cell Function and Interaction
(50)
Affiliations
Broad Institute
Boston University
Roche (Switzerland)
Medical University of Lublin
Brigham and Women's Hospital